Fig. 6: Oxethazaine inhibits ESCC tumor growth and metastasis in vivo. | Cell Death & Disease

Fig. 6: Oxethazaine inhibits ESCC tumor growth and metastasis in vivo.

From: Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A

Fig. 6

A Photographs of tumors for EG20 (n = 8), LEG110 (n = 9), LEG34 (n = 10). B Tumor growth curve after oxethazaine treated for EG20 (n = 8), LEG110 (n = 9), LEG34 (n = 10). C Tumor weight after oxethazaine treated for EG20 (n = 8), LEG110 (n = 9), LEG34 (n = 10). D Representative images for metastasis location of mice in the vehicle and oxethazaine treatment group are shown. E Representative images for lung metastasis in the vehicle and oxethazaine treatment group are shown. F Effect of oxethazaine treatment on tumor metastasis compared to the vehicle-treated group. The asterisks (**) indicate a significant (p < 0.01) decrease in mCherry fluorescent radiant efficiency compared to control. G HE staining was used to detect the pathological changes of mice lung.

Back to article page